Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.

Kemp, J P; Cook, D A; Incaudo, G A; Corren, J; Kalberg, C; Emmett, A; Cox, F M; Rickard, K

Kemp, J P; Cook, D A; Incaudo, G A; Corren, J; Kalberg, C; Emmett, A; Cox, F M; Rickard, K.

Affiliation

Kemp JP; Allergy & Asthma Medical Group and Research Center, APC, San Diego, Calif. 92123, USA.

J Allergy Clin Immunol ; 101(2 Pt 1): 188-95, 1998 Feb.

Article in En | MEDLINE | ID: mdl-9500751

Subject(s)

Adrenal Cortex Hormones/administration & dosage; Adrenergic beta-Agonists/therapeutic use; Albuterol/analogs & derivatives; Asthma/drug therapy; Bronchodilator Agents/therapeutic use; Administration, Inhalation; Adolescent; Adrenergic beta-Agonists/adverse effects; Adult; Aged; Aged, 80 and over; Albuterol/adverse effects; Albuterol/therapeutic use; Bronchodilator Agents/adverse effects; Child; Double-Blind Method; Female; Forced Expiratory Volume/drug effects; Humans; Male; Middle Aged; Peak Expiratory Flow Rate/drug effects; Placebos; Quality of Life; Salmeterol Xinafoate

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Bronchodilator Agents / Adrenal Cortex Hormones / Adrenergic beta-Agonists / Albuterol Type of study: Clinical_trials Aspects: Patient_preference Limits: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Language: En Journal: J Allergy Clin Immunol Year: 1998 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links